Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Verified Market Research | PRODUCT CODE: 1630088

Cover Image

PUBLISHER: Verified Market Research | PRODUCT CODE: 1630088

Latin America Specialized Formula Medical Nutrition Market By Application, By Type, By Region And Forecast

PUBLISHED:
PAGES: 202 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Single User License
USD 3950
Multi User License
USD 4850
Enterprise User License
USD 7550

Add to Cart

Latin America Specialized Formula Medical Nutrition Market Size And Forecast

Latin America Specialized Formula Medical Nutrition Market Size was valued at USD 1.6 Billion in 2024 and is projected to reach USD 2.71 Billion by 2031, growing at a CAGR of 7.47% from 2024 to 2031.

The growing scope of the e-commerce platform has a major impact on the specialized medical nutrition product market. The e-commerce platform is expected to increase geographic penetration by offering an online distribution channel. This is expected to drive the demand for specialized formula medical nutrition. The Latin America Specialized Formula Medical Nutrition Market provides a holistic market evaluation. The report offers comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Latin America Specialized Formula Medical Nutrition Market Size And Forecast

Latin America Specialized Formula Medical Nutrition Market Size was valued at USD 1.6 Billion in 2024 and is projected to reach USD 2.71 Billion by 2031, growing at a CAGR of 7.47% from 2024 to 2031.

The growing scope of the e-commerce platform has a major impact on the specialized medical nutrition product market. The e-commerce platform is expected to increase geographic penetration by offering an online distribution channel. This is expected to drive the demand for specialized formula medical nutrition. The Latin America Specialized Formula Medical Nutrition Market provides a holistic market evaluation. The report offers comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Latin America Specialized Formula Medical Nutrition Market: Segmentation Analysis

The Latin America Specialized Formula Medical Nutrition Market is segmented based on Type And Application.

Latin America Specialized Formula Medical Nutrition Market, By Type

  • Infant
  • Enteral
  • Parenteral

Based on Type, the market is bifurcated into infant, enteral, and parenteral. The Infant medical nutrition Type segment accounted for the largest market share in 2018 and is expected to grow at the highest CAGR during the forecast period. These products are formulated as the sole source of nutrition to satisfy the special nutritional requirements of infants with specific diseases, disorders, or medical conditions during the first months of life until the appropriate complementary feeding is introduced. For instance, specialized formulas have been developed for the dietary management of infants born in premature conditions, infants suffering from severe protein allergies, infants with disorders of fat metabolism, and other acute and chronic gastrointestinal disorders.

Latin America Specialized Formula Medical Nutrition Market, By Application

  • Adult
  • Geriatric
  • Pediatric

Based on Application, Latin America Specialized Formula Medical Nutrition Market is bifurcated into Adult, Geriatric, and Pediatric.

  • Key Players in Latin America Specialized Formula Medical Nutrition Market
  • The "Latin America Specialized Formula Medical Nutrition Market" study report will provide valuable insight with an emphasis on the Latin America market including some of the major players such as Nutricion Medica, Meiji Holdings, Medtrition, Baxter International, B. Braun Melsungen, Fresenius Kabi, Mead Johnson, Abbott Laboratories, Danone Nutricia and others.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Product Code: 11435

TABLE OF CONTENTS

1 INTRODUCTION 11

  • 1.1 MARKET DEFINITION 11
  • 1.2 MARKET SEGMENTATION 12
  • 1.3 RESEARCH TIMELINES 13
  • 1.4 ASSUMPTIONS 13
  • 1.5 LIMITATIONS 14

2 RESEARCH METHODOLOGY 15

  • 2.1 DATA MINING 15
  • 2.2 SECONDARY RESEARCH 15
  • 2.3 PRIMARY RESEARCH 15
  • 2.4 SUBJECT MATTER EXPERT ADVICE 16
  • 2.5 QUALITY CHECK 16
  • 2.6 FINAL REVIEW 16
  • 2.7 DATA TRIANGULATION 16
  • 2.8 BOTTOM-UP APPROACH 17
  • 2.9 TOP DOWN APPROACH 18
  • 2.10 RESEARCH FLOW 18
  • 2.11 DATA SOURCES 19

3 EXECUTIVE SUMMARY 20

  • 3.1 MARKET OVERVIEW 20
  • 3.2 LATIN AMERICA SPECIALIZED FORMULA MEDICAL NUTRITION MARKET COUNTRY ANALYSIS (CAGR %) 21
  • 3.3 LATIN AMERICA SPECIALIZED FORMULA MEDICAL NUTRITION MARKET, BY APPLICATION (USD MILLION) 22
  • 3.4 LATIN AMERICA SPECIALIZED FORMULA MEDICAL NUTRITION MARKET, BY TYPE (USD MILLION) 23
  • 3.5 FUTURE MARKET OPPORTUNITIES 24
  • 3.6 LATIN AMERICA MARKET SPLIT 25

4 MARKET OUTLOOK 26

  • 4.1 MARKET DRIVERS 26
    • 4.1.1 GROWING SCOPE OF ECOMMERCE PLATFORM 26
    • 4.1.2 RISING NUMBER OF WORKING WOMEN 27
  • 4.2 MARKET CHALLENGES 28
    • 4.2.1 LACK OF MEDICAL AWARENESS 28

5 MARKET, BY TYPE 29

  • 5.1 OVERVIEW 29
  • 5.2 INFANT MEDICAL NUTRITION PRODUCTS 30
  • 5.3 ENTERAL MEDICAL NUTRITION PRODUCTS 31
  • 5.4 PARENTERAL MEDICAL NUTRITION PRODUCTS 31

6 MARKET, BY APPLICATION 33

  • 6.1 OVERVIEW 33
  • 6.2 ADULT 34
  • 6.3 GERIATRIC 35
  • 6.4 PEDIATRIC 35

7 LATIN AMERICA MARKET OUTLOOK 36

  • 7.1 LATIN AMERICA 36

8 COMPETITIVE LANDSCAPE 49

  • 8.1 OVERVIEW 49
  • 8.2 KEY DEVELOPMENT STRATEGIES 49
  • 8.3 COMPANY SHARE ANALYSIS 50

9 COMPANY PROFILES 51

  • 9.1 MEIJI HOLDINGS 51
    • 9.1.1 COMPANY OVERVIEW 51
    • 9.1.2 COMPANY INSIGHTS 51
    • 9.1.3 SEGMENT BREAKDOWN 52
    • 9.1.4 PRODUCT BENCHMARKING 52
  • 9.2 MEAD JOHNSON (RECKITT BENCKISER) 53
    • 9.2.1 COMPANY OVERVIEW 53
    • 9.2.2 COMPANY INSIGHTS 53
    • 9.2.3 SEGMENT BREAKDOWN 54
    • 9.2.4 PRODUCT BENCHMARKING 54
    • 9.2.5 KEY DEVELOPMENTS 54
  • 9.3 BAXTER INTERNATIONAL 56
    • 9.3.1 COMPANY OVERVIEW 56
    • 9.3.2 COMPANY INSIGHTS 56
    • 9.3.3 SEGMENT BREAKDOWN 56
    • 9.3.4 PRODUCT BENCHMARKING 57
    • 9.3.5 KEY DEVELOPMENTS 57
  • 9.4 DANONE S.A. 59
    • 9.4.1 COMPANY OVERVIEW 59
    • 9.4.2 COMPANY INSIGHTS 59
    • 9.4.3 SEGMENT BREAKDOWN 60
    • 9.4.4 PRODUCT BENCHMARKING 60
    • 9.4.5 KEY DEVELOPMENTS 60
    • 9.4.6 SWOT ANALYSIS 61
  • 9.5 NESTLE 62
    • 9.5.1 COMPANY OVERVIEW 62
    • 9.5.2 COMPANY INSIGHTS 62
    • 9.5.3 SEGMENT BREAKDOWN 63
    • 9.5.4 PRODUCT BENCHMARKING 63
    • 9.5.5 KEY DEVELOPMENTS 63
    • 9.5.6 SWOT ANALYSIS 64
  • 9.6 B. BRAUN MELSUNGEN 65
    • 9.6.1 COMPANY OVERVIEW 65
    • 9.6.2 COMPANY INSIGHTS 65
    • 9.6.3 SEGMENT BREAKDOWN 65
    • 9.6.4 PRODUCT BENCHMARKING 66
    • 9.6.5 KEY DEVELOPMENTS 66
  • 9.7 FRESENIUS KABI 67
    • 9.7.1 COMPANY OVERVIEW 67
    • 9.7.2 COMPANY INSIGHTS 67
    • 9.7.3 SEGMENT BREAKDOWN 67
    • 9.7.4 PRODUCT BENCHMARKING 68
    • 9.7.5 KEY DEVELOPMENTS 68
  • 9.8 ABBOTT LABORATORIES 69
    • 9.8.1 COMPANY OVERVIEW 69
    • 9.8.2 COMPANY INSIGHTS 69
    • 9.8.3 SEGMENT BREAKDOWN 70
    • 9.8.4 PRODUCT BENCHMARKING 70
    • 9.8.5 SWOT ANALYSIS 71
  • 9.9 PERRIGO 72
    • 9.9.1 COMPANY OVERVIEW 72
    • 9.9.2 COMPANY INSIGHTS 72
    • 9.9.3 SEGMENT BREAKDOWN 72
    • 9.9.4 PRODUCT BENCHMARKING 73
  • 9.10 NUTRICION MEDICA SL 74
    • 9.10.1 COMPANY OVERVIEW 74
    • 9.10.2 COMPANY INSIGHTS 74
    • 9.10.3 PRODUCT BENCHMARKING 74
  • 9.11 VICTUS 75
    • 9.11.1 COMPANY OVERVIEW 75
    • 9.11.2 COMPANY INSIGHTS 75
    • 9.11.3 PRODUCT BENCHMARKING 75
  • 9.12 MEDTRITION, INC. 76
    • 9.12.1 COMPANY OVERVIEW 76
    • 9.12.2 COMPANY INSIGHTS 76
    • 9.12.3 PRODUCT BENCHMARKING 76
  • 9.13 AJINOMOTO CAMBROOKE, INC. (CAMBROOKE THERAPEUTICS, INC.) 77
    • 9.13.1 COMPANY OVERVIEW 77
    • 9.13.2 COMPANY INSIGHTS 77
    • 9.13.3 PRODUCT BENCHMARKING 77
    • 9.13.4 KEY DEVELOPMENTS 78
  • 9.14 KATE FARMS 79
    • 9.14.1 COMPANY OVERVIEW 79
    • 9.14.2 COMPANY INSIGHTS 79
    • 9.14.3 PRODUCT BENCHMARKING 79
    • 9.14.4 KEY DEVELOPMENTS 79
  • 9.15 SICHUAN KELUN PHARMACEUTICAL CO., LTD. 80
    • 9.15.1 COMPANY OVERVIEW 80
    • 9.15.2 COMPANY INSIGHTS 80
    • 9.15.3 SEGMENT BREAKDOWN 80
    • 9.15.4 PRODUCT BENCHMARKING 81
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!